SOC status:Duty analyst on shift

UK Cyber Defence
VulnerabilityModified

CVE-2011-3386

Unspecified vulnerability in Medtronic Paradigm wireless insulin pump 512, 522, 712, and 722 allows remote attackers to modify the delivery of an insulin bolus dose and cause a denial of service (adverse human health effects) via unspecified vectors…

MEDIUM 4.0EPSS 1.45%

Does this matter?

Lower severity and a low EPSS score (1.45%). Track it; it rarely justifies an emergency change on its own.

Description

Unspecified vulnerability in Medtronic Paradigm wireless insulin pump 512, 522, 712, and 722 allows remote attackers to modify the delivery of an insulin bolus dose and cause a denial of service (adverse human health effects) via unspecified vectors involving wireless communications and knowledge of the device's serial number, as demonstrated by Jerome Radcliffe at the Black Hat USA conference in August 2011. NOTE: the vendor has disputed the severity of this issue, saying "we believe the risk of deliberate, malicious, or unauthorized manipulation of medical devices is extremely low... we strongly believe it would be extremely difficult for a third-party to wirelessly tamper with your insulin pump... you would be able to detect tones on the insulin pump that weren't intentionally programmed and could intervene accordingly."

CVSS 2.0
4.0 MEDIUMAV:N/AC:H/Au:N/C:N/I:P/A:P
EPSS
1.45% probability · 73th percentile
Public exploits
None in Exploit-DB
CISA KEV
Not listed
Affected
medtronic/paradigm wireless insulin pump
Source
cve@mitre.org
EPSS trend
0%3%5%26 October 2026: 1.45%26 October 202626 October 2026

EPSS 1.5% since 26 October 2026; no change recorded yet. Points are recorded when the score first appears and whenever it moves by a percentage point or more.

Source: NVD record, EPSS from FIRST.org, KEV from CISA, exploits from Exploit-DB. Refreshed daily. Download this record as JSON.